During the past decade, Hospital Can Misses conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 1 clinical trials were completed, i.e. on average, 16.7% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Can Misses" #1 sponsor was "Ipsen" with 2 trials, followed by "Celgene" with 1 trials sponsored, "Corporacion Parc Tauli" with 1 trials sponsored, "Fundacion SEIMC-GESIDA" with 1 trials sponsored and "Fundación Pública Andaluza Progreso y Salud" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Can Misses" #1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator and "Roche Farma, S.A" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Can Misses" are "Arthritis, Rheumatoid" (1 trials), "Bone Metastasis" (1 trials), "Cancer Pain" (1 trials), "Covid19" (1 trials) and "Leukemia, Myelomonocytic, Chronic" (1 trials). Many other conditions were trialed in "Hospital Can Misses" in a lesser frequency.

Most popular intervention types in "Hospital Can Misses" are "Drug" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Cloxacilin" (1 trials), "Cloxacillin" (1 trials), "Either Wait and See, or Supportive Treatment, or Active Treatment at physician discretion" (1 trials), "Levofloxacin" (1 trials) and "Tanezumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Can Misses" are 7 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Hospital Can Misses". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Hospital Can Misses, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Can Misses, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".